Daxor Corporation

Daxor Corporation is a global leader in blood volume measurement technology, focused on innovation in this field. They developed and market the BVA-100 (Blood Volume Analyzer), the first FDA-cleared diagnostic blood test that provides safe, accurate, and objective quantification of blood volume status and composition. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis, with a vision of achieving optimal blood volume for all patients.

Daxor's BVA-100 technology has been utilized in over 65,000 tests and is employed daily in major medical centers across the United States. Over 145 peer-reviewed studies have established the value of Blood Volume Analysis (BVA), demonstrating its potential to improve patient outcomes by informing treatment strategies in a broad range of medical and surgical conditions, including heart failure and critical care. Daxor continues to invest in research and development, working on a new generation of point-of-care blood volume analyzers to improve patient care and expand the benefits of their technology.

Daxor Corporation is a global leader in blood volume measurement technology dedicated to innovating blood volume testing. The company's mission is to advance healthcare by enabling optimal fluid management through blood volume analysis, aiming to achieve optimal blood volume for all patients. Their vision is to end the debate on fluid management by providing clinicians with the tools they need to make precise and informed decisions regarding blood volume.

Daxor Corporation fosters a collaborative and innovative culture that is driven by a shared commitment to improving patient outcomes through optimal fluid management. The company values hard work, dedication, and a passion for advancing healthcare. Daxor's culture is marked by a strong emphasis on research and development, as well as a focus on building strong relationships with healthcare professionals to ensure the successful implementation and utilization of their blood volume analysis technology.